Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
09/2003
09/09/2003US6617324 Substituted pyrazoles as p38 kinase inhibitors
09/04/2003WO2003072578A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
09/04/2003WO2003045313A3 2-aminoquinoline compounds
09/04/2003WO2003022790A3 Biphenylene compounds
09/04/2003US20030166963 Using tertiary amine catalyst
09/04/2003US20030166703 Method of treatment
09/04/2003US20030166674 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
09/04/2003US20030166654 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
09/04/2003CA2475773A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1339712A1 3-substituted quinuclidines and their use as nicotinic agonists
09/03/2003EP1235826B1 Quinuclidine acrylamides
09/02/2003US6613900 Cephalotaxane derivatives and process for their preparation
08/2003
08/28/2003WO2003070731A2 Azabicyclic compounds for the treatment of disease
08/28/2003WO2003070728A2 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
08/28/2003WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2476624A1 Azabicyclic compounds for the treatment of disease
08/28/2003CA2476417A1 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/27/2003EP1337274A2 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/26/2003US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof
08/21/2003WO2003068749A1 Vanilloid receptor modulators
08/21/2003WO2003055878A8 2-heteroarylcarboxylic acid amides
08/21/2003WO2003018549A3 Bicyclic compounds as inhibitors of chemokine binding to us28
08/21/2003US20030158224 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents
08/14/2003WO2003066099A1 2,4,6-triamino-1,3,5-triazine derivative
08/14/2003WO2002070653A3 Peptide deformylase inhibitors
08/14/2003US20030153595 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/13/2003EP0665843B1 Substituted quinuclidines as substance p antagonists
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/07/2003WO2003064420A1 Novel optically active compounds, method for kinetic optical resolution of carboxylic acid derivatives and catalysts therefor
08/07/2003WO2002048150A3 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/07/2003US20030149055 Bicyclic compounds as inhibitors of chemokine binding to US28
08/07/2003US20030149036 Substituted benzothiazole amide derivatives
08/07/2003US20030149024 For therapy of central nervous system disorders such as diseases and conditions related to sleeping, eating, perceiving pain, controlling body temperature, controlling blood pressure, depression, anxiety, schizophrenia
08/07/2003US20030149017 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc.
08/07/2003CA2474721A1 Novel optically active compounds, method for kinetic optical resolution of carboxylic acid derivatives and catalysts therefor
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
07/2003
07/31/2003WO2003062233A1 2-acylaminothiazole derivative or salt thereof
07/31/2003US20030143700 Specific, asymmetric reduction of 3-quinuclidinone using tropinone reductase-I in the presence of a reduced coenzyme to produce (R)-3-quinuclidinol; high optical purity
07/29/2003US6599917 A squalene-synthesizing enzyme inhibitor, a cholesterol biosynthesis inhibitor and a triglyceride biosynthesis inhibitor
07/29/2003US6599916 Quinuclidine-substituted heteroaryl moieties for treatment of disease
07/24/2003US20030139443 Anxiolytic agents; veterinary medicine
07/24/2003US20030139400 Controlling cell differentiation; antiinflammatory agents
07/24/2003US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
07/24/2003US20030138376 A compressed tablets comprising an embedded polymer matrix, insoluble and disintegrable in the solvents, removed by filtration, separation from a formed soluble product
07/23/2003CN1432019A Hygromycin derivatives for treatment of bacterial and protozoal infections
07/22/2003US6596869 Reacting cyanoquinuclidine compound with isoamyl nitrite for nitrosation
07/22/2003CA2228572C Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
07/17/2003US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
07/16/2003EP1326853A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
07/16/2003EP1326830A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
07/10/2003WO2003055878A1 2-heteroarylcarboxylic acid amides
07/10/2003US20030130305 Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
07/10/2003US20030130285 Controlling cell differentiation, cell proliferation
07/09/2003EP0823906B1 Piperazino derivatives as neurokinin antagonists
07/09/2003EP0759921B1 Process for the preparation of azabicyclic derivatives
07/09/2003CN1429197A Shortened synthesis of 3,3-diarylpropylamine derivatives
07/09/2003CN1429133A Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
07/03/2003WO2003053966A2 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
07/02/2003EP1181290B1 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
07/02/2003CN1427840A Azabicyclic carbamates and their use as alpha-7 nicotinic acetyl choline receptor agonists
07/02/2003CN1113059C Pipeazino derivatives as neurokinin antagonists
07/01/2003US6586446 Chemotaxic cytokine agonists or antagonists such as N(3-acetylphlenyl)-N'-(-2-((-3-((4-fluorophenyl)methyl)-8 -azabicyclo(3.2.1)oct-8-yl)methyl)-(2R)-1-cyclohexyl)urea, used as antiinflammatory agents for asthma or allergies
07/01/2003CA2120919C New ligands for asymmetric dihydroxylation: multiple cinchona alkaloid units attached to a central heterocyclic core
06/2003
06/26/2003WO2003051874A1 Bicyclic n-arylamides
06/26/2003US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives
06/25/2003EP0777652B1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
06/25/2003CN1426410A Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof
06/19/2003WO2003050088A1 Substituted heterocyclic carboxamides with antithrombotic activity
06/19/2003WO2003049741A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003US20030114439 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/19/2003US20030114423 Arylamines as inhibitors of chemokine binding to US28
06/19/2003CA2469596A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/18/2003EP1319000A1 1-azabicyclo 2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/11/2003EP1318200A2 Methods for producing optically active alcohols
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors
06/11/2003CN1423651A New use and novel N-azabicyclo-amide derivatives
06/05/2003WO2003045948A1 Novel phase transfer catalyst and method for producing alpha-amino acid using the same
06/05/2003WO2003045940A2 Benzazepine derivatives and their use as 5-ht ligands
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003US20030105124 Substituted benzolactam compounds
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2468010A1 Benzazepine derivatives and their use as 5-ht ligands
06/04/2003EP1315493A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
06/04/2003EP1017395A4 Method for treating premenstrual or late luteal phase syndrome
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1110499C Spiro-quinuclidine derivatives, their preparation and use
06/03/2003US6573395 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine))
05/2003
05/30/2003WO2003043991A1 Heteroaryl carboxylic acid amides
05/30/2003WO2002085848A8 Synthesis of pancratistatin prodrugs
05/28/2003EP1189903B1 Novel benzo[f]naphthyridine, preparation and compositions containing them
05/22/2003WO2003042210A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 58